background research predicting the public health and fiscal impact of supervised injection facilities (sifs), across different cities in canada, has reported positive results on the reduction of hiv cases among people who inject drugs (pwid). most of the existing studies have focused on the outcomes of insite, located in the vancouver downtown eastside (dtes). previous attention has not been af...

conclusions we found a large impact due to nsps for reducing the occurance of hiv among active drug injectors who have been provided sufficient needles and syringes. the coverage of nsps needs to be increased to observe such significant impact. results given the output of the model, we found that among the pwid with sufficient coverage of nsps the hiv rate is 1.02%, while those with insufficien...

despite the fact that hiv epidemic is mainly driven by injection drug use in iran, partners of people who inject drugs (pwid) have been seriously neglected in terms of effective preventive interventions. currently, sexual partners of pwid might have access to some harm reduction services at voluntary counselling and testing (vct) centers; however, their needs have not been effectively targeted ...

Introduction: Sexual and injection behaviors increase the risk of HIV transmission in people who inject drugs (PWID). We aimed to determine prevalence sexual drug that PWID hospitalized for infections related use Maine. also examined factors influenced their perception willingness take pre-exposure prophylaxis (PrEP).

Injecting drug use is one of the leading risk factors for infections and drug-related deaths. Despite these risks, many people who inject drugs (PWID) continue to despite access alternati...

Abstract Injection-related infections require prolonged antibiotic therapy. Outpatient parenteral antimicrobial therapy (OPAT) has been shown to be feasible for people who inject drugs (PWID) in some settings. We report a national survey on practice patterns and attitudes of infectious diseases (ID) clinicians the U.S. regarding use OPAT PWID.

“We are witnessing a revolution in the treatment of hepatitis C virus.... There is no question that these treatments that can save millions of lives must be made universally available at an affordable price.” – Francois Barre-Sinoussi, President of the International AIDS Society [1] Globally, approximately 184 million people are chronically infected with the Hepatitis C virus (HCV), the majorit...

Introduction: People who inject drugs (PWID) are at increased risk for preventable, communicable infections, such as hepatitis B. Preventive care, B vaccination, is often delivered through primary care providers (PCPs). However, PWID may not have access to PCPs and, therefore, receive preventive other sites. We aimed characterize PCP and use among in Maine.